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Exploiting cyanine dye J-aggregates/monomer
equilibrium in hydrophobic protein pockets for
efficient multi-step phototherapy: an innovative
concept for smart nanotheranostics†
Matías L. Picchio, a Julian Bergueiro, b,c Stefanie Wedepohl, b
Roque J. Minari, d Cecilia I. Alvarez Igarzabal, a Luis M. Gugliotta,d
Julio C. Cuggino *d and Marcelo Calderón *e,f
After several decades of development in the field of near-infrared (NIR) dyes for photothermal therapy
(PTT), indocyanine green (ICG) still remains the only FDA-approved NIR contrast agent. However, upon
NIR light irradiation ICG can react with molecular oxygen to form reactive oxygen species and degrade
the ICG core, losing the convenient dye properties. In this work, we introduce a new approach for
expanding the application of ICG in nanotheranostics, which relies on the confinement of self-organized
J-type aggregates in hydrophobic protein domains acting as monomer depots. Upon the fast photo-
bleaching, while the dye is irradiated, this strategy permits the equilibrium-driven monomer replacement
after each irradiation cycle that radically increases the systems’ effectivity and applicability. Gadolinium-
doped casein micelles were designed to prove this novel concept at the same time as endowing the
nanosystems with further magnetic resonance imaging (MRI) ability for dual-modal imaging-guided PTT.
By teaching a new trick to a very old dog, the clinical prospect of ICG will undoubtedly be boosted laying
the foundation for novel therapeutics. It is anticipated that future research could be expanded to other
relevant J-aggregates-forming cyanine dyes or nanocrystal formulations of poorly water-soluble
photosensitizers.
1. Introduction
Photothermal therapy (PTT) is one of the most efficient non-
invasive therapies that can induce cellular death of malignant
tumors with minimal side effects compared with traditional
chemotherapy or radiotherapy.1,2 With the emergence of the
innovative concept of oncolytic nanoreactors, PTT has gained
renewed attention in the last three years, as it can be synergis-
tically combined in cascade reactions with other therapeutic
modalities as starvation, oxygenation and/or chemodynamic
therapies.3–6
Near-infrared (NIR) irradiation with wavelengths in the
range of 700–1100 nm, are usually used in PTT to achieve high
tissue penetration because living tissues display negligible
absorbance and autofluorescence in this NIR region.7 Among
the many NIR photothermal agents available, noble-
metal-based nanostructures,8,9 carbon nanomaterials,10–12 and
semiconductor13,14 nanoparticles have been extensively
studied in cancer therapy. However, clinical translation of this
type of nanomaterials has been limited due to their non-
degradable nature that jeopardizes long-term biosafety.15 For
this reason, organic dyes are usually preferred as contrast
agents for PTT. Although an assortment of organic chromo-
phores has been developed in the last decade, indocyanine
green (ICG) is currently the only NIR-absorbing dye approved
by the US food and drug administration (FDA).16 However, the
clinical use of ICG has been restricted due to its poor optical
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stability, low aqueous solubility, and short blood residence
time (half-life of 4 min).17 To tackle these limitations, extensive
effort has been made to encapsulate ICG in various nano-
particle formulations, including liposomes,18 micelles,19 and
polymeric nanoparticles.20 These strategies have proven to be
effective for addressing the dye pharmacokinetics, but the
photothermal degradation of ICG still remains the main chal-
lenge that has hampered its widespread use in clinical
applications.21,22
In 1936, E. Jelley discovered the molecular aggregation
phenomenon of pseudo-isocyanine chloride (PIC),23 introdu-
cing the concept of J-aggregates which have a bathochromic
shift as a hallmark. Since then, plenty of work has been done
concerning the light absorption properties of cyanine dyes.
One year later, Scheibe conducted a comprehensive study
using different organic cyanines, solvents, dye concentrations,
and temperatures, concluding that the bathochromic shift in
the J-band absorption spectrum is due to reversible supramo-
lecular self-organization of the dye monomers.24,25 ICG is a
cyanine dye that also undergoes such organization process.
Recently, Dai et al. demonstrated that ICG self-organized
into J-type aggregates (J-ICG) exhibits significantly improved
photothermal stability as compared with the monomeric
dye.26 These J-aggregates, ranging 5–20 nm in diameter,27 are
featured by a narrow red-shifted absorbance peak at 890 nm,
and interestingly, they coexist in equilibrium with monomeric
and dimeric dye forms. Unfortunately, these promising assem-
blies fail in in vivo applications as they are not thermo-
dynamically stable in serum and dissociate within minutes.28
Under this scenario, we hypothesized that J-ICG could be
confined in a hydrophobic environment and prevent their
uncontrolled dissociation. Moreover, the J-aggregate/monomer
equilibrium could be exploited to improve the ICG perform-
ance in light to heat transduction derived from its poor photo-
stability. Indeed, confined J-ICG could act as a monomer reser-
voir where photobleached ICG monomer would be quickly
replaced by the J-ICG/monomer equilibrium (Scheme 1).
Consequently, multiple NIR-irradiation steps could be efficien-
tly performed with minimal detriment to the heat generation
in each cycle.
In order to prove this novel concept, we proposed confin-
ing J-ICG into the hydrophobic pockets of a casein micellar
structure. The choice of this type of nanocarrier was motiva-
ted by two key points. On the one hand, ICG has a high
binding affinity for proteins such as serum albumin29,30 or
ferritin.31 Thus, an effective interaction can also be envi-
sioned for caseins as they have many hydrophobic domains
available for dye stabilization. Besides, ICG could ionically
interact with cationic and anionic groups from glutamic acid,
aspartic acid, and lysine residues of caseins. On the other
hand, by designing a protein-based nanocarrier, we intend to
address characteristic long-term toxicity issues, the bottleneck
for the clinical translation of several promising nanomedi-
cines. Conveniently for biological applications, casein
micelles (CM) can be degraded by enzymes like trypsin or
cathepsin B, typically overexpressed in tumor microenviron-
ments, ensuring an efficient body clearance after nanocarrier
application.32,33
Altogether, CM fit the requirements as a J-aggregates stabi-
lization platform but still needs to prove their versatility in
multimodal applications. Indeed, CMs stability in biological
environments is itself a main concern for nanocarrier
design.34 To address this point, we evaluated the covalent
crosslinking of CMs via carbodiimide chemistry using diethyl-
enetriaminepentaacetic acid gadolinium(III) (DTPAGd) as a
reticulating agent (Fig. 1). Gadolinium (Gd3+)-based contrast
agents were widely used for enabling magnetic resonance
imaging (MRI) or magnetic resonance angiography (MRA) in
nanovehicles.35,36 For example, Gd3+-decorated polymeric
nanomaterials have shown an increased Gd3+ tumor accumu-
lation and improved MRI detection.37–39 Moreover, Gd3+ com-
plexes are compatible with photothermal dyes like ICG,
enabling their combination for dual-modal imaging and
phototherapy-synergized tumor ablation.40
Scheme 1 Illustration of the concept of J-ICG/monomer equilibrium-driven dye reconstitution. J-ICG are stabilized into hydrophobic domains of
β-casein, one of the major components of the micelles.
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In the study presented herein we engineered Gd3+-decorated
CMs that can stabilize J-ICG into their hydrophobic pockets
acting as a reservoir for equilibrium-driven monomer dye
reconstitution. Various micelle formulations were prepared by
varying the content of the reticulating agent to control their
nanostructure and resistance against cathepsin B as a model
protease. In vitro studies showed that the extra stabilization
offered by this type of biocompatible micelles can guarantee
the long-term supply of ICG monomer into cancer cells and
achieve a higher efficiency as PTT agent. With dual-modal
MRI/NIR-fluorescence imaging (NIRFI) and multi-step PTT
capabilities, our platform has the potential to open up new
avenues in nanotheranostics.
2. Results and discussion
We followed a two-step procedure for the construction of our
protein-based nanocarriers (Fig. 1). In the first step, CM were
prepared following a protocol already described by our group
elsewhere.34 This method is based on the re-assemblage of CM
using a CaCl2 solution that stabilizes the micelles with ionic
interactions between Ca2+ and the phosphoserine residues of
casein. Stable micelles with sizes in the range of 125–150 nm
and with low dispersity and high reproducibility were obtained
(see Fig. S1 of the ESI†).
In the second step, DTPAGd was incorporated into CM by
using amidation methodology. First, the free acid groups of
DTPAGd were activated to N-hydroxysuccinimide form and
subsequently reacted with the free amino groups of casein.
This strategy aimed to confer structural stability to the
micelles as an extra crosslinking point and provide the
system with MRI capability. Different amounts of DTPAGd
were tested to find the CM decoration possibilities that also
ensure that the parental physicochemical properties are
maintained. Thus, four amounts of DTPAGd were used to
reach Gd3+ incorporations of 1.6 (CM-Gd2), 4.4 (CM-Gd4), 6.4
(CM-Gd6), and 7.3 weight % (CM-Gd7) as was confirmed by
ICP-MS.
The sizes of the Gd3+ decorated CM (CM-Gdx) were
measured by dynamic light scattering (DLS) at 37 °C and pH
7.4 and 5 emulating physiological conditions of plasma and
endolysosomal compartments, respectively (Fig. 2a). The
CM-Gdx presented Z-averages by DLS in the range between 140
and 165 nm at plasma pH and 37 °C. The obtained sizes were
confirmed by nanoparticle tracking analysis (NTA) at a lower
concentration (thousand times below the casein critical
micelle concentration) (see Fig. S2a of the ESI†). These size
values were similar to the ones obtained for reassembled CM
(128 nm), indicating a negligible inter-micelle crosslinking. A
clear hydrodynamic diameter trend at different crosslinking
degrees was not observed, having in all cases similar values.
This behaviour suggests that ionic assembly in the nanostruc-
turation step turned the micelles into a relatively stable tem-
plate, limiting volume changes upon further covalent reticula-
tion. Similar results were obtained at an emulated lysosomal
pH of 5. But in this case, CM and the least crosslinked nano-
carrier (CM-Gd2) were not colloidally stable and underwent
aggregation. Such aggregation phenomenon is probably due to
the electrostatic destabilization of those less rigid nano-
structures, as the isoelectric point of casein is 4.6 and an
approximately neutral charge is expected for the micelles at
pH 5. These results prove that the covalent stabilization by
DTPAGd in the CM-Gd improved their colloidal stability in
Fig. 1 General procedure for yielding the CM-Gd nanocarriers. Step 1: Re-assembly of CM through calcium ionic interactions. Step 2: Micelles
crosslinking by using DTPAGd as a reticulating agent.
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mild acidic conditions. In this sense, it is desirable that the
nanocarrier maintains its structure in the bloodstream long
enough to guarantee its accumulation in the tumour target
site. Bearing this in mind, further stability studies were per-
formed for CM-Gdx by following the average size by DLS using
urea and strong alkaline pH (pH 12) as destabilizing agents
(Fig. 2b). These agents were selected because they can disrupt
hydrogen bonding and hydrophobic interactions, and solubil-
ize colloidal calcium, respectively.41,42 While CM were rapidly
dissociated after the addition of urea or at pH 12, all the
CM-Gdx maintained their structural integrity, and only small
increases in their average size were observed. This result shows
the effectiveness of the covalent crosslinking process which
maintains the casein chain of the micelles bound.
In addition, the morphologies of CM-Gd2 and CM-Gd7 were
analyzed by scanning transmission electron microscopy
(STEM) (Fig. 2c). CM-Gd7 showed a more compact structure
than CM-Gd2, probably due to a densely crosslinked network
was obtained for this system, which agrees with the stability
behavior discussed above. CM-Gd2 presented a greater dia-
meter (200–220 nm) in a dry state than CM-Gd7 (130–150 nm),
according to the crosslinking degree of these nanosystems.
Cancer-associated proteases are commonly overexpressed
in the tumour microenvironment, which has been widely
used for triggering the release of oncologic drugs in smart
modalities.43 With our nanocarrier design we expect to
exploit this proteases overexpression for promoting body
clearance after therapy. In this sense, it is desirable that
micelles conserve their structural integrity long enough to
ensure J-ICG stabilization during the treatment before being
degraded. Starting from this premise, we hypothesized that
the proteolytic cleavage rate of the micelles could be con-
trolled by the crosslinking density of these nanostructures. To
shed some light on this, we studied the degradation behav-
iour of CM-Gdx by DLS, using cathepsin B as a model pro-
tease at a physiologically relevant concentration. The evol-
Fig. 2 (a) Hydrodynamic size (bars) and PDI (dots) in emulated physiological conditions. (b) Colloidal stability of CM-Gdx after addition of urea or
strong alkaline medium at 25 °C. (c) Morphologies of CM-Gd2 (i and iii) and CM-Gd7 (ii and iv) determined by STEM at different magnifications. (d)
Change of number of particles in dispersion upon proteolytic degradation with cathepsin B, expressed as derived count rate (DCR) measured by
DLS.
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ution of the derived count rate (DCR) was followed over time
(Fig. 2d), as this parameter is directly related to the number of
particles in the dispersion. As it can be seen, DCR decreased
early and steadily for the least crosslinked system suggesting a
fast disassembly of the micelle structure upon addition of
cathepsin B. Similar behaviour was observed for CM-Gd4 and
CM-Gd6. Still, in these cases, the onset of the DCR decay,
which could be correlated to the beginning of the micelles
degradation, occurred slightly later than CM-Gd2, 90 and
180 min, respectively. Interestingly, in contrast with these
results, the most crosslinked nanocarrier (CM-Gd7) showed a
relatively constant value of DCR over the experiment,
suggesting a very slow fragmentation for this system.
Additional evidence of this phenomenon was found when ana-
lyzing the number-weighted particle size distributions (PSD) of
CM-Gd7, which showed a shifting over time to smaller sizes
(Fig. S2b of the ESI†). We hypothesized that highly compact
nanonetworks might act as a barrier to the enzyme’s pene-
tration into the micelles, limiting the protein degradation rate.
Altogether, these results demonstrate that by increasing the
crosslinking density of the micelles, the rate of proteolytic
degradation could be controlled for an effective therapeutic
application. Indeed, this robust nanostructure confers superior
stability to CM-Gd7 in physiological environments, and thus it
was chosen for proving our concept of J-ICG stabilization and
equilibrium-driven monomer supply.
J-ICG in water at room temperature are in equilibrium with
their monomeric and dimeric form of the dye and each struc-
ture presents a different NIR characteristic absorption
maximum of: monomeric (780 nm), dimeric (715 nm), and
J-ICGs (895 nm) (Fig. 3a).26,44 In our strategy, J-ICG confined in
CM-Gd7 (CM-Gd7-J-ICG) serves as a reservoir for the long-term
supply of ICG monomer. For this, we tested the stabilization
properties of CM-Gd7 by using different amounts of encapsu-
lated J-ICG (1, 5, 10, and 15 wt%). In all cases, encapsulation
efficiencies (EE) larger than 90% were found (Fig. 3b). The col-
loidal stability of CM-Gd7-J-ICG, for a dye concentration of
15 wt%, was evaluated by DLS in different media (Fig. S3†).
The obtained sizes were 159, 166, and 165 nm in water, buffers
pH 7.4, and pH 5, respectively, in good agreement with the
size of the unloaded system.
We also evaluated the in situ J-aggregation of ICG within
the micelles, but interestingly the dye self-assembly was not
attained even at high temperature, probably due to strong
protein/dye interactions, which hampered the self-organization
of the monomer molecules (see Fig. S4 of the ESI† for more
details). The stability of J-ICG aggregates encapsulated in
CCM-Gd7 was investigated following the evolution over time of
Fig. 3 (a) UV-Vis spectra of ICG and J-ICG showing their characteristic absorption peaks. (b) Encapsulation efficiency (EE) and loading capacity (LC)
of J-ICG in CM-Gd7 for different micelles/dye ratios. Evolution over time of UV-Vis spectra of (c) free J-ICG and (d) CM-Gd7-J-ICG.
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the characteristic J-ICG trace in the UV-Vis region using non-
encapsulated J-ICG as a control. J-ICG was preserved in the
interior of the micelles for at least 10 days, doubling the stabi-
lity of non-encapsulated J-ICG, which was dissociated in 5 days
(Fig. 3c and d). These results suggest that the encapsulation of
J-ICG in our nanocarrier notably increases its stability long
enough to be applied in PTT.
To validate our proposed concept of equilibrium-driven ICG
monomer reconstitution, the NIR-light to heat transducing
capability of the CM-Gd7-J-ICG was studied by recording the
heat generation upon repeated NIR laser (785 nm) irradiation
cycles. As expected, ICG in its monomeric form was photo-
bleached upon laser irradiation, with a notable decrease in the
maximum temperature reached after each cycle (Fig. 4a). On
the contrary, J-ICG as a control showed virtually the same per-
formance in all four irradiation cycles (reaching temperatures
as high as 68 °C), supporting the concept of using them as
ICG monomer depots. CM-Gd7-J-ICG showed a heat generation
superior to free ICG monomer but unexpectedly lower than
J-ICG (at a dye concentration of 25 μg mL−1) (Fig. 4a). In order
to get insight into this behaviour we studied the change of the
NIR characteristic absorption of ICG, J-ICG, and CM-Gd7-J-ICG
upon each irradiation cycle. It becomes obvious that the
irradiation of the monomer always results in a continuous
decrease of their characteristic absorption peaks at 715 and
780 nm upon each cycle (Fig. S5a†). In contrast, when irradiat-
ing J-ICG at 785 nm the ICG photodegradation drove the disas-
sembly of the J-aggregate, showing an important decrease of
its characteristic peak at 895 while maintaining the absor-
bance of the dimeric and monomeric form unchanged
(Fig. 4b). In other words, J-ICG acts as depots for the continu-
ous supply of monomer/dimer ICG. Similar behaviour was
observed for CM-Gd7-J-ICG, but curiously, confined J-ICG dis-
assembled faster than the free form so that no aggregates were
evidenced from the end of the second cycle (Fig. 4c). We specu-
late that this unexpected behaviour could be related to the
generation of local gradients of high temperatures in the con-
fined environment that can accelerate the disassembly rate of
the aggregated form, as they can degrade above 80 °C.44
Nevertheless, the temperature values reached by CM-Gd7-J-ICG
after four cycles of irradiation (around 59 °C at the tested con-
centration) are high enough to provoke cellular ablation.45 In
fact, the photothermal efficiencies of free J-ICG and our nano-
platform calculated from a single ON/OFF cycle were quite
similar, 13% and 11%, respectively (see Fig. S5b and eqn
(S1)†). Ultimately, we checked the integrity of the protein nano-
carriers after multiple photothermal applications (four cycles)
by analyzing their PSD by DLS. After irradiations, no signifi-
cant changes were found in the PSD, supporting the robust-
ness of our nanosystem (data not shown).
In our design, Gd3+-complex was chosen as a functional
crosslinker to endow to the system MRI capabilities. This prop-
Fig. 4 (a) Temperature changes of ICG, J-ICG, and CM-Gd7-J-ICG aqueous dispersion at the concentration of 25 μg mL−1 over four cycles of NIR-
laser irradiation. Evolution of UV spectra of (b) J-ICG and (c) CM-Gd7-J-ICG after each cycle of NIR-laser irradiation. (d) T1 and T2 relaxivities (r1, r2)
for CM-Gd7 nanocarrier. Inset: T1-Weighted MR images of 2 wt% agarose and 8 mg mL
−1 CM-Gd7.
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erty combined with the NIRFI ability of the cyanine dye turn
this nanoplatform into an attractive alternative for smart
nanotheranostic. To confirm CM-Gd7-J-ICG capabilities as an
MRI contrast agent, we measured the T1 and T2 relaxation time
of the micelles at different concentrations. Relaxivities r1 and
r2 were 4.72 and 12.40 mM
−1 s−1, respectively (Fig. 4d).
Interestingly, CM-Gd7 has an r1 value comparable to other
commercially available Gd-based contrast agents, such as
Magnevist (4.25 mM−1 s−1).46 In this point, it is worth men-
tioning that the incorporation of J-ICG did not significantly
affect the MRI ability of the protein nanocarrier as r1 of
CM-Gd7-J-ICG was 4.02 mM
−1 s−1, suggesting a negligible
Gd3+/dye interaction (see Fig. S6†). These values make the
system a promising T1 contrast agent at standard doses.
In order to characterize the performance of CM-Gd7-J-ICG
nanoprobes in the biological system, we studied their in vitro
cellular uptake by microscopy. For reference, we included free
J-ICG and ICG in the uptake study at equivalent concen-
trations, as well as non-loaded micelles as a control. HeLa cells
were incubated with the different agents for 6 h and then
imaged in a confocal laser-scanning microscope using the
same settings for all samples. As previously reported, ICG fluo-
rescence is completely quenched when monomers self-assem-
ble in J-aggregates (see Fig. S7†).26 Nevertheless, strong fluo-
rescence signals could be seen in the cytoplasm of HeLa cells
incubated with CM-Gd7-J-ICG (Fig. 5a), indicating that J-ICG
could be partially dissociated into ICG monomer when
micelles are efficiently internalized into cells. Although deeper
Fig. 5 Confocal laser scanning microscopy images of HeLa cells incubated for 6 h with (a) CM-Gd7-J-ICG nanoprobe, (b) J-ICG, (c) ICG monomer,
and (d) CM-Gd7. Blue: nuclei stained with DAPI, red: ICG. Scale bar: 50 µm.
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biological studies are needed to shed light on this phenom-
enon, internalization-responsive fluorescence might result
from intracellular dye leakage followed by strong interactions
with amphiphilic membrane proteins and phospholipids.26
Interestingly, CCM-Gd7-J-ICG showed a higher fluorescence
intensity inside the cells than free J-ICG (Fig. 5b) and ICG
(Fig. 5c), which allows speculating that encapsulation of the
dye increased its internalization. These results clearly show
that CM-Gd7-J-ICG hold great promise as a nanotheranostic
combining MIR and NIRFI diagnostic modalities.
As a proof of concept for the application as theranostic PTT
agents, we used real-time cell analysis (RTCA) to investigate
the influence of CM-Gd7-J-ICG on cell viability and mor-
phology over time, and after irradiation with NIR light (Fig. 6).
HeLa cells incubated with culture medium alone, free ICG and
empty CM-Gd7 micelles were used as a control.
We found that cells incubated with CM-Gd7 and CM-Gd7-
J-ICG showed a very similar growth profile as cells treated with
medium only, as can be seen by their similar cell indices (CI)
over time. However, cells incubated with free ICG showed a
stagnating cell growth, with the growth curve flattened. These
results demonstrate the very good compatibility of the carrier
with the cells, as expected, but also confirm that we can
indeed reduce some negative side effects of free ICG by encap-
sulation of its assembled form into casein micelles.
After NIR irradiation, cells incubated with ICG and
CCM-Gd7-J-ICG were highly affected, as seen by a large drop in
their cell index values. This observation can be attributed to
the strong generation of heat by the photothermal agents,
causing immediate cell death by ablation. Irradiation of cells
treated with CM-Gd7 alone and medium alone had however,
no discernible effect (also compare to Fig. S8†). As free J-ICG is
not stable in biological environments and rapidly dissociates
into its monomeric form, it was excluded from this experi-
ment. These results show the great potential of CCM-Gd7-J-ICG
as a therapeutic nanoagent and encourage us to extend this
research to more complex microenvironments, as solid tumors
in future studies, where the benefits of the J-aggregates will be
assessed in detail.
3. Conclusions
We have explored an innovative approach to tackle the photo-
degradability of ICG, relying on the stabilization of J-type
aggregates in hydrophobic protein pockets which can act as
depots of the dye monomer/dimer forms through an equili-
brium-driven mechanism. To validate this concept we fabri-
cated a biodegradable casein-based nanocarrier using gado-
pentetic acid as a crosslinking agent. This complex provided
the nanocarriers with high stability in physiological media and
against dissociating agents, and generated sizes in the range
between 140 and 165 nm. We found that by varying the cross-
linking density of the protein micelles its degradation rate by
cathepsin B, a tumor-associated protease, could be controlled
beneficially to ensure body clearance after treatment. The
design of this nanoagent was also aimed to address the poor
stability of the J-ICG in biological environments, a major
problem that limits their therapeutic outcome. By encapsulat-
ing this self-assembled dye into the micelles, its dissociation
under dilute conditions was significantly slowed down or even
hindered for at least 10 days. Therefore, it is expected that
J-aggregates are stable in serum after parenteral administration
expanding the prospects of these nano-assemblies for in vivo
applications. Once stabilized within the micelles, J-ICG pro-
motes the continuous supply of monomer/dimer allowing mul-
tiple irradiation cycles with superior photothermal perform-
ance as compared to free ICG. The main pitfall of the confine-
ment of J-ICG was found to be an acceleration of their disas-
sembly rate in comparison to free J-ICG. Although the reasons
for this behavior are still under investigation, we hypothesized
that J-ICG may be degraded at high temperatures in the con-
fined environment. Nevertheless, we could confirm the excel-
lent compatibility of the carriers with cultured cells in vitro:
Fig. 6 Real-time cell analysis of HeLa cells incubated with CM-Gd7-J-ICG, free ICG monomer, CM-Gd7, and medium only. 24 h after seeding, the
compounds were added (*) and after another 24 h, cells were irradiated with a NIR laser for 5 minutes.
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while the free ICG had a negative effect on cell growth, incu-
bation with the carrier alone as well as the carrier with encap-
sulated J-ICG left the cells unaffected. After irradiation with
NIR light however, sufficient heat to cause immediate cell
death by ablation was developed, confirming the functionality
and potential as a photothermal agent.
In summary, this novel approach of equilibrium-driven
monomer dye supply combined with our functional nano-
carrier allowed to create an innovative nanoplatform that can
simultaneously serve as an MRI/NIRFI multimodal probe and
an effective photothermal agent for smart theranostics. The
concept of J-aggregates confinement in polymer nanocarriers
becoming a new paradigm for theranostic is still in its infancy,
but it is foreseen that this work will lay the foundation for
future investigations focusing on new strategies of stabilization
for other cyanine dyes.
4. Experimental
4.1. Materials
The following chemicals were used as purchased: Casein
sodium salt from bovine milk (Sigma-Aldrich); diethyl-
enetriaminepentaacetic acid gadolinium(III) dihydrogen salt
hydrate (DTPAGd, 97%, Sigma-Aldrich); N-(3-dimethyl-
aminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC,
Sigma-Aldrich); N-hydroxysuccinimide (NHS, Sigma-Aldrich);
indocyanine green (ICG, polymethine dye, Sigma-Aldrich),
calcium chloride dihydrate (CaCl2·2H2O, Grüssing), sodium
chloride (NaCl, VWR Chemicals), acetic acid glacial
(CH3COOH, Fisher Chemicals), sodium acetate (C2H3NaO2,
Grüssing), sodium dihydrogen phosphate (NaH2PO4,
Grüssing), disodium hydrogen phosphate (Na2HPO4,
Grüssing), urea (ReagentPlus®, ≥99.5%, Sigma-Aldrich),
microscopy grade uranyl acetate 1 wt% solution (UAc, EMS),
deuterium oxide (D2O, Sigma-Aldrich), cathepsin B from
human placenta (≥5 units per mg protein, Sigma-Aldrich),
ethylenediaminetetraacetic acid (EDTA, BioUltra, ≥99% Sigma-
Aldrich), dithiothreitol (DTT, BioXtra ≥99%, Sigma-Aldrich)
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT, Sigma-Aldrich). Ultrapure water was used
throughout the work.
4.2 Synthesis of Gd-decorated casein micelles
We firstly re-assembled casein micelles (CM) from sodium
caseinate following a previously reported protocol.34 Briefly,
protein solution (50 mg mL−1) was dialyzed against a 0.5 mM
CaCl2 solution for 4 h, using a dialysis membrane with a mole-
cular weight cut off (MWCO) of 10 kDa. After the dialysis
process, re-assembled micelles were kept at 4 °C for 24 h and
then centrifuged at 10 000 rpm for 10 min to precipitate
protein aggregates. Ultimately, re-constituted micelles were
crosslinked with different amounts of DTPAGd (0.2–0.9 mg
mL−1) aiming to endow the nanocarriers with both colloidal
stability and MRI ability. For this, the crosslinking agent was
firstly activated with EDC and NHS (at a molar ratio of 1 : 2 : 2)
in phosphate-buffered saline (PBS, pH 6.9, 0.1 M) for 2 h.
Then, the activated DTPAGd solution was added to micelles
dispersion (at a final concentration of 10 mg mL−1), previously
heat up to 70 °C for 30 min, and it left reacting for 2 h. The
obtained Gd-decorated crosslinking micelles were purified by
dialysis (MWCO = 1000 kDa) for 48 h in water and sub-
sequently stored at 4 °C. The products were named as CM-Gd2,
CM-Gd4, CM-Gd6, and CM-Gd7 according to their functionali-
zation values of 1.6, 4.4, 6.4, and 7.3% in weight of the Gd3+-
decorated CM.
4.3 Size and structural stability of the CM-Gd
The hydrodynamic diameter (Z-average) and polydispersity
index (PDI) of the nanoprobes was measured by dynamic light
scattering (DLS) using a Zetasizer Nano ZS (Malvern
Instruments). Measurements were carried out at a scattering
angle of 173° and a laser wavelength of 633 nm. Dispersions
(1 mg mL−1) in water, 10 mM PBS pH 7.4, or 10 mM acetate-
buffered saline (ABS) pH 5, respectively, were measured at 25
and 37 °C. DLS was also used to study the structural and col-
loidal stability of the micelles against urea as a dissociating
agent. Micelles dispersions (8 mg mL−1) were diluted until
1 mg mL−1 in 8 M urea at pH 9.3. Non-crosslinked micelles
(non-CM) were used as control.
Nanoparticle tracking analysis (NTA) was performed to
further confirm the crosslinked nature of the nanocarriers.
NTA measurements were carried out using a NanoSight NS500
equipment (Malvern) at 25 °C from water-diluted samples (2 ×
10−4 mg mL−1, much lower than the CAS critical micellar con-
centration, 0.1 mg mL−1).
4.4 Determination of Gd concentration in CM-Gd
The concentration of Gd3+ in CM-Gd samples was measured by
inductively coupled plasma mass spectrometry (ICP-MS). All
samples were digested using microwave-assisted acid digestion
with 69% HNO3 and 30% H2O2 for 30 min at 200 °C and 160
bars. Measurements were performed with a quadrupole ICP
mass spectrometer (iCAP-Q, Thermo Fisher Scientific GmbH,
Dreieich, Germany) equipped with a PFA ST Nebulizer, a
quartz cyclonic spray chamber, and a 2.5 mm quartz injector
(all from Thermo Fisher Scientific) using the 158Gd and
103Rh as an internal standard. Calibrations were performed
using an ionic standard of DTPAGd in 3.5% HNO3 solutions
ranging from 0.1 to 100 ppb. The internal standard was added
to each sample. The gas flow for the cool gas and the auxiliary
gas were set to 14 L min−1, and 0.65 L min−1 respectively. The
sample flow rate was 0.4 mL min−1. All isotopes were analysed
using the collision cell technique at 5 mL min−1 collision gas
flow (93% He and 7% H2).
4.5 Degradability of the CM-Gd against proteases
The proteolytic degradation of the nanosystems was analyzed
by DLS following the change of their hydrodynamic diameters
over time. Cathepsin B was used as model protease, as it is
commonly overexpressed in several malignant tumors. Thus,
10 μL of 2 mM EDTA, 10 μL of 5 mM DTT, and 5 μL of cathep-
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sin B (100 units per mL) were added to 75 μL of CM-Gd (8 mg
mL−1) and their size was immediately measured each 90 min,
for 24 h at 37.0 ± 0.5 °C.
4.6 Scanning transmission electron microscopy (STEM)
The morphology of Gd-decorated micelles was studied by
means of STEM using a Hitachi SU8030 microscope. To this
effect, a drop of diluted dispersion (0.01 wt% of solids
content) was placed on a carbon-coated copper grid. After
drying, a drop of 1 wt% UAc solution was added as a staining
agent.
4.7 Preparation of ICG J-aggregates
J-ICG were prepared following the procedure described else-
where.44 Briefly, ICG aqueous solution (10 mg mL−1) was
heated at 65 °C for 20 h and then dialyzed against water for
24 h to remove any free dye. The formation of J-ICG was con-
firmed by UV-Vis spectroscopy using a Cary 100 Bio equipment
(Agilent). Finally, the J-aggregates solution was stored at 4 °C
for later utilization.
4.8 Loading of J-ICG into CM-Gd nanoprobes
For J-ICG loading, different amounts of dye nanoaggregates
(1–15% based on protein) were added to the micelle dispersion
(8 mg mL−1) and magnetically stirred overnight. The CM-Gd-
J-ICG nanoprobe was purified using a Vivaspin™ tube (MWCO
1000 kDa) centrifuging at 6000 rpm for 10 min and washing
with water. Several cycles were performed until free
J-aggregates were not detected in the washing water by UV–Vis
spectroscopy.
The in situ formation of J-ICG within CM-Gd was evaluated
through the encapsulation of ICG monomer into the protein
nanoprobe, followed by either heating of the micelle dis-
persion at 65 °C for 20 h or aging at 4 °C for 7 days. For ICG
loading and nanocarrier purification, the same procedure as
for J-ICG was used.
The encapsulated amounts of J-ICG or ICG were calculated
by UV–Vis spectroscopy, measuring the absorbance of the dyes
at 895 or 780 nm, respectively, and correlated with a cali-
bration curve in water (see Fig. S9 of the ESI†). Encapsulation
efficiency (EE) was defined as the weight percentage of the dye
loaded versus the amount added to the micelles dispersion
and loading capacity (LC) was calculated as the weight percen-
tage of dye relative to the micelles.
The stability of J-ICG into CM-Gd was evaluated following
the evolution over time of the characteristic J-ICG trace in the
UV-Vis region using non-encapsulated J-ICG as a control. The
measurements were carried out at a dye concentration of 5 μg
mL−1.
4.9 In vitro laser irradiation of the photothermal nanoagents
The heat production of ICG, J-ICG, and CM-Gd7-J-ICG nano-
probes was measured at 25 μg mL−1, placing a 100 μL sample
in a transparent Eppendorf tube and irradiating with an infra-
red diode laser module (FC-D-785 CNI, λ = 785 nm, 500 mW).
The solution was irradiated for 300 s (ON) and then cooled for
420 s (OFF). During ON/OFF cycle, the temperature variation
was monitored with an infrared camera (FLIR E30, 25° Optic,
60 Hz). The ON/OFF cycle was repeated four times, and
samples were tested in triplicate. Additionally, the photother-
mal stability of the theranostic nanoagents after each ON/OFF
cycle was evaluated by UV–Vis spectroscopy at 5 μg mL−1 dye
concentration. The photothermal conversion efficiency (η) of
J-ICG and CM-Gd-J-ICG was determined from the steady-state
temperature rise of 5 μg mL−1 dispersions, using the following
equation according to Korgel et al.47 (see ESI† for calculation
details):
η ¼ hA Tmax  Tsurrð Þ  Qin;surr
Ið1 10AλÞ ð1Þ
where h is the heat transfer coefficient, A is the surface area of
the container, Tmax is the maximum steady-state temperature,
Tsurr is the ambient surrounding temperature, I is the laser
power, Aλ is the absorbance at the excitation wavelength of
785 nm. Qin,surr is the heat input due to light absorption by the
solvent, which was measured independently and found to be
3.25 mW. The quantity hA was calculated by measuring the
rate of temperature drop after removing the laser source (see
ESI† for calculation details).
4.10 MRI ability of the CM-Gd nanoprobe
CM-Gd7 dispersions with different Gd
3+ concentrations
ranging from 0.1 mM to 1 mM were prepared in a 2 wt%
agarose gel and scanned at 25 °C on a Magritek Kea2 spectro-
meter operating at 60 MHz for 1H. A 1.4 T permanent magnet
(Varian EM360) was used. Inversion recovery and spin-echo
pulse sequences were used for T1 and T2 measurements,
respectively. Relaxivities, r1 and r2 were calculated by plotting
the relaxation rates (1/ΔT1 and 1/ΔT2) for each sample against
the Gd3+ concentration.
4.11. Cellular uptake
Cellular uptake was visualized by confocal laser scanning
microscopy. For this, HeLa cells were seeded onto coverslips in
24 well plates at a density of 10 000 cells per mL in full culture
medium and incubated overnight at 37 °C and 5% CO2. The
next day, compounds were added and incubated for 6 h at
37 °C. Then, the cell culture supernatant was removed, cells
were washed 3× with PBS and fixed for 20 minutes with 10%
neutral buffered formalin at room temperature. After 3×
washing with PBS, nuclei were stained with DAPI (Carl Roth,
2.5 µg mL−1 in PBS) for 30 minutes and washed again before
mounting on microscope slides using ProTaqs(R) MountFluor
mounting medium (Quartett GmbH). Images were acquired
using LASX software on a Leica SP8 system. Fluorescence was
collected in red channel: Ex 633 nm, Em 700–800 nm.
4.12 In vitro monitoring of cells treated with nanoagents and
NIR irradiation
We monitored the influence of the nanoagents on cells with
and without NIR irradiation using real-time cell analysis
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(RTCA) on an xCELLigence DP system (ACEA Biosciences Inc.).
10 000 HeLa cells per well were seeded into two E-plates 16
and grown for 24 h. Then, fresh medium including either
CM-Gd7, free ICG monomer, free J-ICG, and CM-Gd7-J-ICG was
added. Two plates were prepared identically. After another
24 h, E-plates were released from the device and respective
wells of one E-plate were irradiated for 5 minutes with a NIR
laser (FC-D-785 CNI, λ = 785 nm, 500 mW) from a distance of
2 cm. The other E-plate was treated the same (handling
control) but not irradiated (see Fig. S8†). Cell indices (CI) are
derived from impedance measurements through gold electro-
des on the bottom of the E-plate wells, where the impedance
corresponds to the surface area covered by cells. The area
covered by cells is influenced by their morphology (spread out
vs. rounded up) and number of cells, which allows drawing
conclusions about the cell proliferation and death events.
Monitoring was continued for another 2 days after irradiation.
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